Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
You dont have to guess what treatment is right for you
Retatrutide is an unlicensed investigational triple incretin receptor agonist by Eli Lilly
Injections are particularly appropriate for those with: Pernicious anaemia, an autoimmune condition affecting B12 absorption Conditions affecting the stomach or small intestine, such as Crohns disease or coeliac disease Those who have had gastric surgery or bariatric procedures Strict vegans and vegetarians not meeting their B12 needs through food or oral supplements For those who can absorb B12 normally, oral supplements are generally an effective and well-evidenced alternative to injections
Most users experience mild energy increases within the first week, with more noticeable metabolic effects emerging after 2-3 weeks of consistent use
Yields 5 mg/mL
US$ 22.97
US$ 23.12
US$ 22.03
US$ 28.76
US$ 29.17
